Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

Cancel

BSE Code : 532523 | NSE Symbol : BIOCON | ISIN : INE376G01013 | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |

(16-May-25 09:38) Biocon's subsidiary get US FDA nod for anticoagulant medication Rivaroxaban
(09-May-25 09:23) Board of Biocon recommends final dividend
(09-May-25 09:23) Biocon to hold AGM
(09-May-25 07:38) Biocon consolidated net profit rises 154.24% in the March 2025 quarter
(05-May-25 09:31) Biocon edges higher after biologics arm secures multiple market access deals for Yesintek
(24-Apr-25 08:11) Biocon’s board OKs to raise Rs 4,500-cr
(23-Apr-25 20:05) Board of Biocon approves fund raising up to Rs 4,500 cr
(21-Apr-25 09:37) Biocon to consider fund Raising
(15-Apr-25 09:58) Biocon surges on U.S. deal for Eylea copycat drug
(10-Apr-25 11:07) Biocon unit gets U.S. FDA nod for cancer drug biosimilar

1 2 3 4 5 6 7 8 9 10

Biocon Ltd